News

Agreement is expected to help improve the medication delivery process for patients.

New solution is expected to focus on products’ time and temperature-sensitive requirements.

The latest people news happenings over the past month.

Software allows pharmacies to meet legislation’s upcoming Nov. 27 deadline.

The 26,000 square-foot plant with further expand the company’s temperature-controlled services.

Initiative to support developing manufacturers launch new products.

According to a recent TMR study, there is an expected CAGR increase of 5.6%.

Biopharma aims to strengthen field engagement with healthcare professionals.

The 200,000 square-foot manufacturing plant—coming early next year—is expected to help boost capacity of pharma packaging materials.

Buyout gives Advanco a bigger US footprint.

SkyCell’s 1500X containers are the partnership’s centerpiece.

DSCSA compliance was also top of mind at the event.

The series’ marking heads help deliver codes to support both product traceability and anti-counterfeiting efforts.

Expansion expected to create additional production capacity, company says.

Changes to 3PL’s facility feature newly-converted controlled room temperature pallets.

Honor is given to companies that demonstrate a commitment to expanding access to healthcare for people in need.

CDMO’s new facility is expected to be operational by April 2025.

Using AI and data science, ‘plai’ is expected to assist employees with making everyday decisions, including the manufacturing of vaccines.

Strategic engagement offering, known as Inizio Engage, aims to simplify engagement opportunities across the product lifecycle.

The accreditations—granted to the company’s sites in the US, LATAM, and Canada—are given for compliance with specific pharma manufacturer guidelines.

Agreement provides Vizient clients—including hospital systems and healthcare suppliers—with additional access to logistics solutions, such as warehousing and distribution.

Biopharmas are able to industry insight to assist them across the end-to-end product lifecycle.

Sy Pretorius, COO & president of outsourced solutions at Eversana, dives into his new role in the space, after being a veteran in the clinical development sector.

Pharma company claims that the IRA’s drug pricing clauses violate the First and Fifth Amendments.

Partnership intends to reduce treatment costs, while also increasing medication access.

Software company’s branded orchestration platform helps to track chain of identity and chain of custody.

New space will assist pharma companies with cold chain solutions, including commercial product distribution.

However, April numbers show that capacity is up 13.4% compared to April of last year.